220 filings
Page 5 of 11
8-K
z1atjeuky
30 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
p221vw60t1htp
14 Aug 12
Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
12:00am
8-K
iu6zc
10 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
sluc68bix20hi
22 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
3voh38ut8yhl2 ntcug
21 May 12
Termination of a Material Definitive Agreement
12:00am
8-K
qsoyh1
11 May 12
Echo Therapeutics Announces First Quarter 2012 Financial Results
12:00am
8-K
tcveocy
11 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
uzkmupg2zvfhqke2m
9 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
euzsyc5ozhw32yine
19 Mar 12
Echo Therapeutics, Inc. Announces 2011 Financial Results
12:00am
8-K
yh82hnla digh
4 Jan 12
Entry into a Material Definitive Agreement
12:00am
8-K
af194k
27 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
jm574kiwbrp 8zjd6a
6 Dec 11
Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing
12:00am
8-K
zj88b5r
18 Nov 11
Entry into a Material Definitive Agreement
12:00am
8-K
aqaxip 8k42s
8 Nov 11
Echo Therapeutics Announces Third Quarter 2011 Financial Results
12:00am
8-K
aadfe5b8f7qx5sg69
1 Nov 11
Entry into a Material Definitive Agreement
12:00am
8-K
bt1xmemdycr r2g5
16 Aug 11
Echo Therapeutics Announces Second Quarter 2011 Financial Results
12:00am
8-K
yzlhsd wg3bg11az
18 Jul 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
feo8zbccr8uxcelfe5
30 Jun 11
Echo Therapeutics Announces NASDAQ Listing
12:00am
8-K
09xwmdq
15 Jun 11
Departure of Directors or Certain Officers
12:00am
8-K
0gcmw4cy
20 May 11
Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer
12:00am